Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
J. Devillers, E. Bro & F. Millot. (2015) Prediction of the endocrine disruption profile of pesticides. SAR and QSAR in Environmental Research 26:10, pages 831-852.
Read now
Read now
Articles from other publishers (24)
Mangala Hegde, Sosmitha Girisa, Nikunj Naliyadhara, Aviral Kumar, Mohammed S. Alqahtani, Mohamed Abbas, Chakrabhavi Dhananjaya Mohan, Sudha Warrier, Kam Man Hui, Kanchugarakoppal S. Rangappa, Gautam Sethi & Ajaikumar B. Kunnumakkara. (2022) Natural compounds targeting nuclear receptors for effective cancer therapy. Cancer and Metastasis Reviews 42:3, pages 765-822.
Crossref
Crossref
Sawako Shindo, Satoru Kakizaki, Toshiyuki Sakaki, Yuki Kawasaki, Tsutomu Sakuma, Masahiko Negishi & Ryota Shizu. (2023) Phosphorylation of nuclear receptors: Novelty and therapeutic implications. Pharmacology & Therapeutics 248, pages 108477.
Crossref
Crossref
David J Dabbs, Richard S Huang & Jeffrey S Ross. (2022) Novel markers in breast pathology. Histopathology 82:1, pages 119-139.
Crossref
Crossref
Xiang Lu, Ali Huang, Maoxu Xiao, Liang Sun, Jiashun Mao, Guoshun Luo & Hua Xiang. (2020) A new class of 1,3,5-triazine-based selective estrogen receptor degraders (SERDs): Lead optimization, molecular docking and dynamic simulation. Bioorganic Chemistry 97, pages 103666.
Crossref
Crossref
Yongcui Wang, Shilong Chen, Luonan Chen & Yong Wang. (2019) Associating lncRNAs with small molecules via bilevel optimization reveals cancer-related lncRNAs. PLOS Computational Biology 15:12, pages e1007540.
Crossref
Crossref
Yury V. Kuznetsov, Inna S. Levina, Alexander M. Scherbakov, Olga E. Andreeva, Andrey S. Dmitrenok, Oleg R. Malyshev & Igor V. Zavarzin. (2018) 3,20-Dihydroxy-13α-19-norpregna-1,3,5(10)-trienes. Synthesis, structures, and cytotoxic, estrogenic, and antiestrogenic effects. Steroids 137, pages 1-13.
Crossref
Crossref
Nora S Sánchez, Gordon B Mills & Kenna R Mills Shaw. (2017) Precision oncology: neither a silver bullet nor a dream. Pharmacogenomics 18:16, pages 1525-1539.
Crossref
Crossref
Ryeo-Eun Go, Kyung-A Hwang, Cho-Won Kim, Yong-Sub Byun, Ki-Hoan Nam & Kyung-Chul Choi. (2017) Effect of dioxin and 17β-estradiol on the expression of cytochrome P450 1A1 gene via an estrogen receptor dependent pathway in cellular and xenografted models. Environmental Toxicology 32:10, pages 2225-2233.
Crossref
Crossref
Konstanze Gier, Claudia Preininger & Ursula Sauer. (2017) A Chip for Estrogen Receptor Action: Detection of Biomarkers Released by MCF-7 Cells through Estrogenic and Anti-Estrogenic Effects. Sensors 17:8, pages 1760.
Crossref
Crossref
Chengcheng Gong, Zhongyi Yang, Yifei Sun, Jian Zhang, Chunlei Zheng, Leiping Wang, Yongping Zhang, Jing Xue, Zhifeng Yao, Herong Pan, Biyun Wang & Yingjian Zhang. (2017) A preliminary study of 18F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel. Scientific Reports 7:1.
Crossref
Crossref
Jeffrey S. Ross & Laurie M. Gay. (2017) Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer. Pathology 49:2, pages 120-132.
Crossref
Crossref
Wanjun Lin, Jiajun Huang, Xiaolin Liao, Zhongwen Yuan, Senling Feng, Ying Xie & Wenzhe Ma. (2016) Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha. Pharmacological Research 111, pages 849-858.
Crossref
Crossref
Quentin Glenadel & Thierry Billard. (2016) Direct Perfluoroalkylthiolation of Few Chalcogenols. Chinese Journal of Chemistry 34:5, pages 455-458.
Crossref
Crossref
Quentin Glenadel, Mathieu Bordy, Sébastien Alazet, Anis Tlili & Thierry Billard. (2016) Metal-Free Direct Nucleophilic Perfluoroalkylthiolation with Perfluoroalkanesulfenamides. Asian Journal of Organic Chemistry 5:3, pages 428-433.
Crossref
Crossref
Vishal Chandra, Jong Joo Kim, Doris Mangiaracina Benbrook, Anila Dwivedi & Rajani Rai. (2016) Therapeutic options for management of endometrial hyperplasia. Journal of Gynecologic Oncology 27:1.
Crossref
Crossref
Chris De Savi, Robert H. BradburyAlfred A. RabowRichard A. NormanCamila de AlmeidaDavid M. AndrewsPeter BallardDavid ButtarRowena J. CallisGordon S. CurrieJon O. CurwenChris D. DaviesCraig S. DonaldLyman J. L. FeronHelen GingellSteven C. GlossopBarry R. HayterSyeed HussainGalith KaroutchiScott G. LamontPhilip MacFaulThomas A. MossStuart E. PearsonMichael TongeGraeme E. WalkerHazel M. WeirZena Wilson. (2015)
Optimization of a Novel Binding Motif to (
E
)-3-(3,5-Difluoro-4-((1
R
,3
R
)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1
H
-pyrido[3,4-
b
]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist
. Journal of Medicinal Chemistry 58:20, pages 8128-8140.
Crossref
Crossref
Na Huang, Bo Liu, Zhiheng Dong, Wei Mao, Nan Zhang, Changyou Li & Jinshan Cao. (2015) Prostanoid receptors EP2, EP4, and FP are regulated by estradiol in bovine oviductal smooth muscle. Prostaglandins & Other Lipid Mediators 121, pages 170-175.
Crossref
Crossref
Rowena Callis, Alfred Rabow, Michael Tonge, Robert Bradbury, Mairi Challinor, Karen Roberts, Karen Jones & Graeme Walker. (2015) A Screening Assay Cascade to Identify and Characterize Novel Selective Estrogen Receptor Downregulators (SERDs). SLAS Discovery 20:6, pages 748-759.
Crossref
Crossref
Diego Caprioglio & Stephen P. Fletcher. (2015) An alternative synthesis of the breast cancer drug fulvestrant (Faslodex®): catalyst control over C–C bond formation. Chemical Communications 51:80, pages 14866-14868.
Crossref
Crossref
Adam M. Brufsky. (2014) Managing Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer Who Progress on Endocrine Therapies with Inhibitors of the PI3K Pathway. The Breast Journal 20:4, pages 347-357.
Crossref
Crossref
Eugenia Ch Yiannakopoulou. 2014. Omics Approaches in Breast Cancer. Omics Approaches in Breast Cancer
483
498
.
C. Byrne, E. Miclet, I. Broutin, D. Gallo, V. Pelekanou, M. Kampa, E. Castanas, G. Leclercq & Y. Jacquot. (2013) Identification of Polyproline II Regions Derived From the Proline-Rich Nuclear Receptor Coactivators PNRC and PNRC2: New Insights for ERα Coactivator Interactions. Chirality 25:10, pages 628-642.
Crossref
Crossref
Henrik J. Johansson, Betzabe C. Sanchez, Filip Mundt, Jenny Forshed, Aniko Kovacs, Elena Panizza, Lina Hultin-Rosenberg, Bo Lundgren, Ulf Martens, Gyöngyvér Máthé, Zohar Yakhini, Khalil Helou, Kamilla Krawiec, Lena Kanter, Anders Hjerpe, Olle Stål, Barbro K. Linderholm & Janne Lehtiö. (2013) Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer. Nature Communications 4:1.
Crossref
Crossref
Adisorn Ratanaphan. (2012) A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer. International Journal of Molecular Sciences 13:12, pages 14898-14916.
Crossref
Crossref